Found: 427
Select item for more details and to access through your institution.
Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Beyond Anticoagulation: A Comprehensive Review of Non-Vitamin K Oral Anticoagulants (NOACs) in Inflammation and Protease-Activated Receptor Signaling.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8727, doi. 10.3390/ijms25168727
- By:
- Publication type:
- Article
Direct factor Xa inhibitors and the risk of cancer and cancer mortality: A Danish population-based cohort study.
- Published in:
- PLoS Medicine, 2024, v. 21, n. 7, p. 1, doi. 10.1371/journal.pmed.1004400
- By:
- Publication type:
- Article
Spontaneous sublingual hematoma due to warfarin: An emergency presenting to the dermatologist.
- Published in:
- 2016
- By:
- Publication type:
- case study
Dabigatran Potentiates Gemcitabine-Induced Growth Inhibition of Pancreatic Cancer in Mice.
- Published in:
- Molecular Medicine, 2017, v. 23, p. 13, doi. 10.2119/molmed.2016.00214
- By:
- Publication type:
- Article
Effect of SGLT2 Inhibitors on Risk of Stroke in Diabetes: A Meta-Analysis.
- Published in:
- Cerebrovascular Diseases, 2022, v. 51, n. 5, p. 585, doi. 10.1159/000521782
- By:
- Publication type:
- Article
Development of a Rapid Qualitative Screen for Anticoagulant Presence.
- Published in:
- Journal of Applied Laboratory Medicine, 2024, v. 9, n. 2, p. 305, doi. 10.1093/jalm/jfad081
- By:
- Publication type:
- Article
Patients Taking Direct Oral Anticoagulants (DOAC) Undergoing Oral Surgery: A Review of the Literature and a Proposal of a Peri-Operative Management Protocol.
- Published in:
- Healthcare (2227-9032), 2020, v. 8, n. 3, p. 281, doi. 10.3390/healthcare8030281
- By:
- Publication type:
- Article
Budget and health impact of switching eligible patients with atrial fibrillation to lower-dose dabigatran.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2247719
- By:
- Publication type:
- Article
Management of Major Bleeding with the Non-Vitamin K Oral Anticoagulants: the Role of Antidotes.
- Published in:
- Rhythmos, 2016, v. 11, n. 1, p. 1
- By:
- Publication type:
- Article
Dabigatran Etexilate Induces Cytotoxicity in Rat Gastric Epithelial Cell Line via Mitochondrial Reactive Oxygen Species Production.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2508, doi. 10.3390/cells10102508
- By:
- Publication type:
- Article
Assessing the relative contribution of CYP3A-and P-gp-mediated pathways to the overall disposition and drug-drug interaction of dabigatran etexilate using a comprehensive mechanistic physiological-based pharmacokinetic model.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1356273
- By:
- Publication type:
- Article
Dabigatran and Wet AMD, Results From Retinal Pigment Epithelial Cell Monolayers, the Mouse Model of Choroidal Neovascularization, and Patients From the Medicare Data Base.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.896274
- By:
- Publication type:
- Article
Dabigatran: Clinical correlation of drug and its dose with risk of stroke and bleeding.
- Published in:
- Perspectives in Clinical Research, 2023, v. 14, n. 1, p. 26, doi. 10.4103/picr.picr_171_21
- By:
- Publication type:
- Article
Google Bard: Utility in Drug Interactions.
- Published in:
- Scripta Medica, 2023, v. 54, n. 3, p. 311, doi. 10.5937/scriptamed54-45110
- By:
- Publication type:
- Article
The new era of anticoagulation.
- Published in:
- Surgical Neurology International, 2016, v. 7, p. 1, doi. 10.4103/2152-7806.177124
- By:
- Publication type:
- Article
Proposal of an in vitro thrombus-growth model for evaluating anticoagulants.
- Published in:
- Drug Discoveries & Therapeutics, 2022, v. 16, n. 3, p. 135, doi. 10.5582/ddt.2022.01040
- By:
- Publication type:
- Article
Efficacy of dabigatran versus warfarin in patients with acute venous thromboembolism in the presence of thrombophilia: Findings from RE-COVER<sup>®</sup>, RE-COVER™ II, and RE-MEDY™.
- Published in:
- Vascular Medicine, 2016, v. 21, n. 6, p. 506, doi. 10.1177/1358863X16668588
- By:
- Publication type:
- Article
The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 2, p. 79, doi. 10.1111/ejh.13348
- By:
- Publication type:
- Article
Direct acting oral anticoagulants for the treatment of suspected heparin-induced thrombocytopenia.
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 4, p. 332, doi. 10.1111/ejh.12921
- By:
- Publication type:
- Article
Volume replacement strategies do not impair the binding of dabigatran to idarucizumab: Porcine model of hemodilution.
- Published in:
- PLoS ONE, 2019, v. 14, n. 01, p. 1, doi. 10.1371/journal.pone.0209350
- By:
- Publication type:
- Article
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study.
- Published in:
- PLoS ONE, 2018, p. 1, doi. 10.1371/journal.pone.0202575
- By:
- Publication type:
- Article
Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0195950
- By:
- Publication type:
- Article
Length of hospitalization and mortality for bleeding during treatment with warfarin, dabigatran, or rivaroxaban.
- Published in:
- PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193912
- By:
- Publication type:
- Article
Heart Failure Council of Thailand (HFCT) 2019 Heart Failure Guideline: Atrial Fibrillation in Heart Failure Guidelines.
- Published in:
- Journal of the Medical Association of Thailand, 2019, v. 102, n. 4, p. 513
- By:
- Publication type:
- Article
Reversão do Dabigatrano: Abordagem Prática.
- Published in:
- Acta Médica Portuguesa, 2022, v. 35, n. 5, p. 394, doi. 10.20344/amp.17662
- By:
- Publication type:
- Article
Direct oral anticoagulants should often be suspended for longer before neuraxial blockade.
- Published in:
- Acta Anaesthesiologica Scandinavica, 2023, v. 67, n. 5, p. 682, doi. 10.1111/aas.14209
- By:
- Publication type:
- Article
Activated prothrombin complex in the management of direct thrombin inhibitor-associated intracerebral haemorrhage.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
New oral anticoagulants-TURKey (NOAC-TURK): Multicenter cross-sectional study.
- Published in:
- Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2017, v. 17, n. 5, p. 353, doi. 10.14744/AnatolJCardiol.2016.7472
- By:
- Publication type:
- Article
review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?
- Published in:
- Anatolian Journal of Cardiology / Anadolu Kardiyoloji Dergisi, 2015, v. 15, n. 12, p. 1020, doi. 10.5152/AnatolJCardiol.2015.6532
- By:
- Publication type:
- Article
Anticoagulants: What is new and what is the standard?
- Published in:
- Clinical Pharmacology & Therapeutics, 2016, v. 100, n. 2, p. 126, doi. 10.1002/cpt.400
- By:
- Publication type:
- Article
Possible intrusive food interaction with oral dabigatran's anticoagulant activity in a rat models.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2018, v. 17, n. 10, p. 2031, doi. 10.4314/tjpr.v17i10.20
- By:
- Publication type:
- Article
Warfarin is associated with higher rates of epistaxis compared to direct oral anticoagulants: A nationwide propensity score‐weighted study.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 3, p. 501, doi. 10.1111/joim.13498
- By:
- Publication type:
- Article
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study.
- Published in:
- Journal of Internal Medicine, 2018, v. 283, n. 1, p. 45, doi. 10.1111/joim.12683
- By:
- Publication type:
- Article
Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System.
- Published in:
- Heart & Vessels, 2017, v. 32, n. 3, p. 309, doi. 10.1007/s00380-016-0864-4
- By:
- Publication type:
- Article
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin.
- Published in:
- Heart & Vessels, 2017, v. 32, n. 3, p. 326, doi. 10.1007/s00380-016-0871-5
- By:
- Publication type:
- Article
Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban—A European comparative drug utilization study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2021, v. 128, n. 3, p. 440, doi. 10.1111/bcpt.13517
- By:
- Publication type:
- Article
Fatal Adverse Event with Dabigatran in Elderly Patient with Reduced Kidney Function.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2018, v. 123, n. 2, p. 221, doi. 10.1111/bcpt.12985
- By:
- Publication type:
- Article
Idarucizumab for Reversal of Dabigatran Prior to Acute Surgery: A Schematic Approach Based on a Case Report.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2017, v. 120, n. 4, p. 407, doi. 10.1111/bcpt.12696
- By:
- Publication type:
- Article
Dabigatran Concentration: Variability and Potential Bleeding Prediction In 'Real-Life' Patients With Atrial Fibrillation.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2015, v. 117, n. 5, p. 323, doi. 10.1111/bcpt.12417
- By:
- Publication type:
- Article
Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists.
- Published in:
- European Journal of Medical Research, 2016, v. 21, p. 1, doi. 10.1186/s40001-016-0235-8
- By:
- Publication type:
- Article
PD07 Cost-Effectiveness Of Direct Oral Anticoagulants In Chinese Patients With Non-Valvular Atrial Fibrillation.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
PP181 Direct Comparison Of The Effectiveness And Safety Of Apixaban, Dabigatran, Rivaroxaban, And Warfarin: Subgroup Analyses Of Medicare Beneficiaries.
- Published in:
- 2020
- By:
- Publication type:
- Abstract
THE GAP BETWEEN ECONOMIC EVALUATIONS AND CLINICAL PRACTICE: A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS ON DABIGATRAN FOR ATRIAL FIBRILLATION.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Safety and Efficacy of Dabigatran Versus Warfarin in Asian Patients With Atrial Fibrillation.
- Published in:
- Malaysian Journal of Medicine & Health Sciences, 2020, v. 16, n. 4, p. 89
- By:
- Publication type:
- Article
Expression of anti and pro‐inflammatory genes in human endothelial cells activated by 25‐hydroxycholesterol: A comparison of rivaroxaban and dabigatran.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2022, v. 49, n. 8, p. 805, doi. 10.1111/1440-1681.13668
- By:
- Publication type:
- Article
Dual‐target synergistic antithrombotic mechanism of a dabigatran etexilate analogue (HY023016).
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2022, v. 49, n. 5, p. 567, doi. 10.1111/1440-1681.13634
- By:
- Publication type:
- Article
Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in Germany.
- Published in:
- Clinical Epidemiology, 2023, v. 15, p. 827, doi. 10.2147/CLEP.S405585
- By:
- Publication type:
- Article
Effect of an activated charcoal product (DOAC Stop™) intended for extracting DOACs on various other APTT-prolonging anticoagulants.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2019, v. 57, n. 5, p. 690, doi. 10.1515/cclm-2018-0967
- By:
- Publication type:
- Article